AK0406

· Shanghai Ark Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AK0406, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AK0406 Injection in Healthy Adult Participants [Phase 1]

See pricing